La descarga está en progreso. Por favor, espere

La descarga está en progreso. Por favor, espere

Dr. Rommel J Carrillo Várguez. DEMENCIA: El término... MARCO TULIO CICERON (106-43 a.C) Político, orador, escritor, romano En su ensayo,, De Senectute...

Presentaciones similares


Presentación del tema: "Dr. Rommel J Carrillo Várguez. DEMENCIA: El término... MARCO TULIO CICERON (106-43 a.C) Político, orador, escritor, romano En su ensayo,, De Senectute..."— Transcripción de la presentación:

1 Dr. Rommel J Carrillo Várguez

2 DEMENCIA: El término... MARCO TULIO CICERON ( a.C) Político, orador, escritor, romano En su ensayo,, De Senectute... la pérdida de la memoria era consecuencia de una enfermedad ajena a la senectud... Cicerón

3 ALOIS ALZHEIMER. El padre... AUGUSTE D En Noviembre de 1901, se presenta una mujer de 51 años al departamento de psiquiatría de la Universidad Johann Wolfang Goethe en Frankfurt. Cuadro Clínico : deterioro progresivo de memoria, afasia, alucinaciones auditivas, celotipia, paranoia, llanto frecuente e incompetencia psicosocial.

4 ALOIS ALZHEIMER ALOIS ALZHEIMER. El padre... Alois Alzheimer, aborda y hace seguimiento por espacio de 2 años. realizando exploraciones clínicas y neuropsicológicas Alzheimer se traslada a Munich. La paciente es seguida por médicos anónimos. 8 Abril 1906, fallece Auguste D. Se realiza necropsia cerebral. Neurofibrillas

5 ALOIS ALZHEIMER. El padre... El 4 de Noviembre de 1906 durante XXXVII Conferencia de Psiquiatras Alemanes en Tubingen, se presenta el primer reporte anatomo- clínico de la futura enfermedad. Una enfermedad grave caracteristica de la corteza cerebral título de la publicación en 1907 Microscopia Actual Dibujo Original

6 ALOIS ALZHEIMER. El padre... En la cuarta edición de su TRATADO DE PSIQUIATRIA KRAEPELIN, hace mención por primera vez de los casos de Auguste D y otros como la ENFERMEDAD DE ALZHEIMER

7 ¿Y AHORA QUE?

8 Introduction Join our mailing list Tell us what you think! Ask Alzheimer Europe Introduction Guidelines Donations Sponsorship Financial statements Annual report Care manual Provision of care at home Children's book Conference proceedings Legal rights of patients Interesting links Suggest a link Conferences on dementia Suggest an event New on our site European developments Our latest activities Activities of our members Research Other news Introduction Our opinion on... Relevant texts Working groups ResearchIntroduction Involuntary placement Incapable adults Biomedical research Human rights and Biomedicine Palliative care Psychotherapy Introduction Our opinion on... EP Resolutions Relevant texts European projects AE Networking EU funding Clinical trials Genetic testing Introduction Alzheimer projects Disability Forum Neurological Associations Social NGOs Pharmaceutical Industry Introduction Country reports Recommendations Guidelines on restraint Advance directives Summary Full document General guidelines Mechanical restraint Physical restraint Locking doors Tagging Video surveillance Passive alarms Medication as restraint Psychological restraint YOUR COMMENTS... Introduction Onset of the disease Memory and Communication Daily life Changes in mood Changes in behaviour Medical and physical issues Coping with caring Disclosure of the diagnosis Dealing with emotions Care arrangements Independent living Younger people with dementia Memory Communication Disorientation Personal hygiene Dressing Eating and drinking Personal relationship Activities and exercise Safety Living alone Helping children to cope Agitation and nervousness Anger Anxiety and fear Apathy Brusque changes of mood Having depression Frustration Hallucinations Over-reaction Aggressive behaviour Clinging and following Embarrassing behaviour Failure to recognise people Hiding/losing objects Repetitive questioning Sexually behaviour Sleeplessness Wandering Constipation Dental problems Eyesight Fits Hearing Incontinence Jerking movements Moving the person with dementia Loss of manual skills Pressure sores Self-help organisations Looking after yourself Caring in the later stages Arranging residential care Death and bereavement Brain tissue donations Background information EURODEM prevalence rates Statistics Introduction Dementia : definition Alzheimer's disease Other forms of dementia Related disorders What is it? Who is affected? Is it hereditary? Can it be predicted? Diagnosis Treatment Main characteristics Three stages Current research Aids Dementia Complex Alcohol Related Dementia Binswanger's Disease Creutzfeldt-Jacob Disease Lewy-Body Dementia Multi-Infarct Dementia Pick's Disease Down's syndrome Huntington's disease Parkinson's disease Introduction Our full members Our associate members Become full member Become associate member Provision of Care at home Lawnet Intranet Care Manual Children's book ERICA Telephone Helpline Rural areas Early onset dementia Description Manual Introduction Our aims Our statutes Our Board Our staff Annual reports De acuerdo las tendencias actuales de prevalencia de (30-50%) en mayores de 85 años: EPIDEMIA

9 DETERIOROCOGNOSCITIVO: DEMENCIA PSEUDO DEMENCIA PRIMARIA SECUNDARIA ALZHEIMER D. DE PICK CREUTZFEL-JACKOB PARKINSON VASCULAR HUNTINGTON Alcohólica DEPRESION DELIRIUM DISTIROIDISMO PSICOFÁRMACOS DEFICIT NUTRICIONAL

10 SIGLO XX. Criterios Diagnósticos Estudios Epidemiológic os Prevalencia a nivel mundial

11 FISIOPATOLOGIA:

12

13

14 Farmacológico Inhibidores de Colinesterasa Inhibidores de Colinesterasa INHIBIDORES NMDA INHIBIDORES NMDA memantina –AKATINOL- memantina –AKATINOL- Vitaminas, oxigenadores cerebrales, transfusiones de células de embriones transfusiones de células de embriones NO SIRVEN

15

16 SOBRE ESTIMULACION DAÑO NEURONAL MEMANTINA (AKATINOL)

17

18 Otras Opciones Farmacológicas Introduction Join our mailing list Tell us what you think! Ask Alzheimer Europe Introduction Guidelines Donations Sponsorship Financial statements Annual report Care manual Provision of care at home Children's book Conference proceedings Legal rights of patients Interesting links Suggest a link Conferences on dementia Suggest an event New on our site European developments Our latest activities Activities of our members Research Other news Introduction Our opinion on... Relevant texts Working groups ResearchIntroduction Involuntary placement Incapable adults Biomedical research Human rights and Biomedicine Palliative care Psychotherapy Introduction Our opinion on... EP Resolutions Relevant texts European projects AE Networking EU funding Clinical trials Genetic testing Introduction Alzheimer projects Disability Forum Neurological Associations Social NGOs Pharmaceutical Industry Introduction Country reports Recommendations Guidelines on restraint Advance directives Summary Full document General guidelines Mechanical restraint Physical restraint Locking doors Tagging Video surveillance Passive alarms Medication as restraint Psychological restraint YOUR COMMENTS... Introduction Onset of the disease Memory and Communication Daily life Changes in mood Changes in behaviour Medical and physical issues Coping with caring Disclosure of the diagnosis Dealing with emotions Care arrangements Independent living Younger people with dementia Memory Communication Disorientation Personal hygiene Dressing Eating and drinking Personal relationship Activities and exercise Safety Living alone Helping children to cope Agitation and nervousness Anger Anxiety and fear Apathy Brusque changes of mood Having depression Frustration Hallucinations Over-reaction Aggressive behaviour Clinging and following Embarrassing behaviour Failure to recognise people Hiding/losing objects Repetitive questioning Sexually behaviour Sleeplessness Wandering Constipation Dental problems Eyesight Fits Hearing Incontinence Jerking movements Moving the person with dementia Loss of manual skills Pressure sores Self-help organisations Looking after yourself Caring in the later stages Arranging residential care Death and bereavement Brain tissue donations Background information EURODEM prevalence rates Statistics Introduction Dementia : definition Alzheimer's disease Other forms of dementia Related disorders What is it? Who is affected? Is it hereditary? Can it be predicted? Diagnosis Treatment Main characteristics Three stages Current research Aids Dementia Complex Alcohol Related Dementia Binswanger's Disease Creutzfeldt-Jacob Disease Lewy-Body Dementia Multi-Infarct Dementia Pick's Disease Down's syndrome Huntington's disease Parkinson's disease Introduction Our full members Our associate members Become full member Become associate member Provision of Care at home Lawnet Intranet Care Manual Children's book ERICA Telephone Helpline Rural areas Early onset dementia Description Manual Introduction Our aims Our statutes Our Board Our staff Annual reports Combinación de aminoácidos de proteína Beta amiloide con otros prótidos (AN 1792) en fase clínica 20 pacientes 2002 Fase clínica II suspensión del protocolo por presencia de meningitis aséptica en 15 pacientes ussuarios Dublin, Irlanda THE LANCET Neurology Vol 1 May 2002

19

20 CONCLUSIONES 1- hay opciones farmacológicas reales 2- RESULTADOS MODESTOS PERO NOTABLES 3- MEJORAN SINTOMATICAMENTE, CONDUCTUALMENTE Y ¿DETIENEN EVOLUCION? 4- LOS PACIENTES DEBEN RECIBIR ESTOS FARMACOS


Descargar ppt "Dr. Rommel J Carrillo Várguez. DEMENCIA: El término... MARCO TULIO CICERON (106-43 a.C) Político, orador, escritor, romano En su ensayo,, De Senectute..."

Presentaciones similares


Anuncios Google